Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 18 (9), 563-573

Mechanisms of DNA-protein Crosslink Repair

Affiliations
Review

Mechanisms of DNA-protein Crosslink Repair

Julian Stingele et al. Nat Rev Mol Cell Biol.

Abstract

Covalent DNA-protein crosslinks (DPCs, also known as protein adducts) of topoisomerases and other proteins with DNA are highly toxic DNA lesions. Of note, chemical agents that induce DPCs include widely used classes of chemotherapeutics. Their bulkiness blocks virtually every chromatin-based process and makes them intractable for repair by canonical repair pathways. Distinct DPC repair pathways employ unique points of attack and are crucial for the maintenance of genome stability. Tyrosyl-DNA phosphodiesterases (TDPs) directly hydrolyse the covalent linkage between protein and DNA. The MRE11-RAD50-NBS1 (MRN) nuclease complex targets the DNA component of DPCs, excising the fragment affected by the lesion, whereas proteases of the spartan (SPRTN)/weak suppressor of SMT3 protein 1 (Wss1) family target the protein component. Loss of these pathways renders cells sensitive to DPC-inducing chemotherapeutics, and DPC repair pathways are thus attractive targets for combination cancer therapy.

Similar articles

See all similar articles

Cited by 26 articles

See all "Cited by" articles

References

    1. Nat Genet. 2014 Nov;46(11):1239-44 - PubMed
    1. Cancer Res. 2012 Nov 1;72 (21):5588-99 - PubMed
    1. Genetics. 2005 Jun;170(2):591-600 - PubMed
    1. Nat Rev Drug Discov. 2011 Dec 16;11(1):25-36 - PubMed
    1. Trends Biochem Sci. 2015 Feb;40(2):67-71 - PubMed
Feedback